EMA-话题@MedSci

#EMA#

580篇内容 | 2453人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317654, encodeId=317f131e65425, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：接受阿卡拉布替尼单药治疗的慢性淋巴细胞白血病患者的心血管不良事件: 762例患者的汇总分析。, objectType=article, longId=218053, objectId=6f90218053de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f90218053de, replyNumber=0, likeNumber=96, createdTime=2021-10-04, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f90218053de, moduleTitle=HAEMATOLOGICA：接受阿卡拉布替尼单药治疗的慢性淋巴细胞白血病患者的心血管不良事件: 762例患者的汇总分析。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f90218053de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317653, encodeId=3d04131e6539b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Breast Cancer Res ：阿贝西利（Abemaciclib）联合氟维司群治疗绝经前女性HR+/HER2-的晚期乳腺癌疗效:来自MONARCH 2试验的亚组分析, objectType=article, longId=218041, objectId=1ce121804150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ce121804150, replyNumber=0, likeNumber=100, createdTime=2021-10-03, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ce121804150, moduleTitle=Breast Cancer Res ：阿贝西利（Abemaciclib）联合氟维司群治疗绝经前女性HR+/HER2-的晚期乳腺癌疗效:来自MONARCH 2试验的亚组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ce121804150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317652, encodeId=5553131e652c8, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle= A protocol for systematic review and meta-analysis：甲钴胺中药注射液治疗糖尿病周围神经病变, objectType=article, longId=217817, objectId=ef2821e817aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef2821e817aa, replyNumber=0, likeNumber=21, createdTime=2021-09-29, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef2821e817aa, moduleTitle= A protocol for systematic review and meta-analysis：甲钴胺中药注射液治疗糖尿病周围神经病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef2821e817aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317651, encodeId=2bcc131e6516d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haemat：本妥昔单抗联合化疗治疗III/IV期经典霍奇金淋巴瘤的长期预后, objectType=article, longId=217739, objectId=0ff021e739a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ff021e739a7, replyNumber=0, likeNumber=84, createdTime=2021-09-28, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ff021e739a7, moduleTitle=Lancet Haemat：本妥昔单抗联合化疗治疗III/IV期经典霍奇金淋巴瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ff021e739a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317650, encodeId=1368131e65047, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：体外和体内多色报告小鼠品系揭示的单个血小板和巨核细胞形态动力学, objectType=article, longId=217598, objectId=1bdc21e5985c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bdc21e5985c, replyNumber=0, likeNumber=100, createdTime=2021-09-26, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bdc21e5985c, moduleTitle=Haematologica：体外和体内多色报告小鼠品系揭示的单个血小板和巨核细胞形态动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bdc21e5985c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317649, encodeId=f5dc131e64984, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=AMERICAN JOURNAL OF HEMATOLOGY：世界卫生组织定义的嗜酸性粒细胞疾病：2021 年诊断、风险分层和管理更新。, objectType=article, longId=217540, objectId=e89621e540d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e89621e540d2, replyNumber=0, likeNumber=67, createdTime=2021-09-25, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e89621e540d2, moduleTitle=AMERICAN JOURNAL OF HEMATOLOGY：世界卫生组织定义的嗜酸性粒细胞疾病：2021 年诊断、风险分层和管理更新。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e89621e540d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317648, encodeId=aabe131e648b0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：三手烟暴露以性别依赖的方式在子宫内调节血小板功能, objectType=article, longId=217403, objectId=575a21e4032e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=575a21e4032e, replyNumber=0, likeNumber=48, createdTime=2021-09-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=575a21e4032e, moduleTitle=HAEMATOLOGICA：三手烟暴露以性别依赖的方式在子宫内调节血小板功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=575a21e4032e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317647, encodeId=4c24131e647f7, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=INT J LAB HEMATO：外周颗粒状淋巴细胞减少症和畸形白细胞增多症作为 COVID-19 的简单预后标志物, objectType=article, longId=217347, objectId=3d9421e3474e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d9421e3474e, replyNumber=0, likeNumber=58, createdTime=2021-09-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d9421e3474e, moduleTitle=INT J LAB HEMATO：外周颗粒状淋巴细胞减少症和畸形白细胞增多症作为 COVID-19 的简单预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d9421e3474e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317646, encodeId=7508131e646a3, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：口服阿扎胞苷治疗缓解期AML患者的不良事件, objectType=article, longId=216585, objectId=d493216585e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d493216585e2, replyNumber=0, likeNumber=68, createdTime=2021-09-03, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d493216585e2, moduleTitle=J Hematol Oncol：口服阿扎胞苷治疗缓解期AML患者的不良事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d493216585e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317645, encodeId=55ae131e645f8, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Nat Med：Tau蛋白单克隆抗体gosuranemab治疗进行性核上性麻痹的安全性和有效性临床研究, objectType=article, longId=216025, objectId=5632216025b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5632216025b3, replyNumber=0, likeNumber=64, createdTime=2021-08-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5632216025b3, moduleTitle=Nat Med：Tau蛋白单克隆抗体gosuranemab治疗进行性核上性麻痹的安全性和有效性临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5632216025b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317644, encodeId=a855131e6446f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：Venetoclax联合强化化疗治疗AML或高危MDS的效果, objectType=article, longId=215478, objectId=74912154e866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74912154e866, replyNumber=0, likeNumber=57, createdTime=2021-08-10, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74912154e866, moduleTitle=Lancet Haematol：Venetoclax联合强化化疗治疗AML或高危MDS的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74912154e866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317643, encodeId=8147131e64374, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, objectType=article, longId=215018, objectId=3aeb21501886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aeb21501886, replyNumber=0, likeNumber=64, createdTime=2021-07-31, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aeb21501886, moduleTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aeb21501886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317642, encodeId=9246131e642ef, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Int J Hematol：罗米布司汀可有效治疗艾曲波帕难治性再生障碍性贫血, objectType=article, longId=214202, objectId=1c69214202fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c69214202fe, replyNumber=0, likeNumber=59, createdTime=2021-07-15, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c69214202fe, moduleTitle=Int J Hematol：罗米布司汀可有效治疗艾曲波帕难治性再生障碍性贫血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c69214202fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317641, encodeId=670c131e6414a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：PD-1单抗---杰诺单抗注射液(geptanolimab）对外周T细胞淋巴瘤(PTCL) 的疗效与安全性, objectType=article, longId=214110, objectId=d47e2141105c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d47e2141105c, replyNumber=0, likeNumber=110, createdTime=2021-07-14, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d47e2141105c, moduleTitle=J Hematol Oncol：PD-1单抗---杰诺单抗注射液(geptanolimab）对外周T细胞淋巴瘤(PTCL) 的疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d47e2141105c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317640, encodeId=f66b131e6405d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol ：我国不限瘤种PD-L1快要来了，晚期实体瘤患者精准治疗新选择！, objectType=article, longId=213845, objectId=5610213845c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5610213845c0, replyNumber=0, likeNumber=116, createdTime=2021-07-08, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5610213845c0, moduleTitle=J Hematol Oncol ：我国不限瘤种PD-L1快要来了，晚期实体瘤患者精准治疗新选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5610213845c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317639, encodeId=700f131e639f9, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：新发现可揭开运动员使用血液兴奋剂的面纱, objectType=article, longId=213148, objectId=f55521314869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f55521314869, replyNumber=0, likeNumber=94, createdTime=2021-06-25, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f55521314869, moduleTitle=Br J Haematol：新发现可揭开运动员使用血液兴奋剂的面纱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f55521314869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317638, encodeId=2b88131e6380b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：ixazomib口服治疗方案有望成为NDMM患者的良好替代治疗选择, objectType=article, longId=212449, objectId=882221244968, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=882221244968, replyNumber=0, likeNumber=62, createdTime=2021-06-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=882221244968, moduleTitle=Ann Hematol：ixazomib口服治疗方案有望成为NDMM患者的良好替代治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=882221244968)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317637, encodeId=b5fa131e637d3, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：纳武单抗治疗复发或难治性霍奇金淋巴瘤的疗效——真实世界研究证据, objectType=article, longId=212380, objectId=aabc212380dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aabc212380dd, replyNumber=0, likeNumber=81, createdTime=2021-06-08, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aabc212380dd, moduleTitle=Ann Hematol：纳武单抗治疗复发或难治性霍奇金淋巴瘤的疗效——真实世界研究证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aabc212380dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317636, encodeId=0622131e63689, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：多发性骨髓瘤移植后依沙佐米维持治疗中不良事件的管理, objectType=article, longId=212028, objectId=e46e21202860, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e46e21202860, replyNumber=0, likeNumber=67, createdTime=2021-05-31, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e46e21202860, moduleTitle=Ann Hematol：多发性骨髓瘤移植后依沙佐米维持治疗中不良事件的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e46e21202860)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317635, encodeId=aa8e131e63512, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：靶向捕获测序对多发性骨髓瘤进行基因组分析, objectType=article, longId=212025, objectId=656421202596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=656421202596, replyNumber=0, likeNumber=77, createdTime=2021-05-31, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=656421202596, moduleTitle=Br J Haematol：靶向捕获测序对多发性骨髓瘤进行基因组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=656421202596)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：接受阿卡拉布替尼单药治疗的慢性淋巴细胞白血病患者的心血管不良事件: 762例患者的汇总分析。

2021-10-04

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Breast Cancer Res ：阿贝西利（Abemaciclib）联合氟维司群治疗绝经前女性HR+/HER2-的晚期乳腺癌疗效:来自MONARCH 2试验的亚组分析

2021-10-03

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

A protocol for systematic review and meta-analysis：甲钴胺中药注射液治疗糖尿病周围神经病变

2021-09-29

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haemat：本妥昔单抗联合化疗治疗III/IV期经典霍奇金淋巴瘤的长期预后

2021-09-28

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：体外和体内多色报告小鼠品系揭示的单个血小板和巨核细胞形态动力学

2021-09-26

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

AMERICAN JOURNAL OF HEMATOLOGY：世界卫生组织定义的嗜酸性粒细胞疾病：2021 年诊断、风险分层和管理更新。

2021-09-25

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：三手烟暴露以性别依赖的方式在子宫内调节血小板功能

2021-09-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

INT J LAB HEMATO：外周颗粒状淋巴细胞减少症和畸形白细胞增多症作为 COVID-19 的简单预后标志物

2021-09-21

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：口服阿扎胞苷治疗缓解期AML患者的不良事件

2021-09-03

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Nat Med：Tau蛋白单克隆抗体gosuranemab治疗进行性核上性麻痹的安全性和有效性临床研究

2021-08-21

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：Venetoclax联合强化化疗治疗AML或高危MDS的效果

2021-08-10

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究

2021-07-31

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Int J Hematol：罗米布司汀可有效治疗艾曲波帕难治性再生障碍性贫血

2021-07-15

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：PD-1单抗---杰诺单抗注射液(geptanolimab）对外周T细胞淋巴瘤(PTCL) 的疗效与安全性

2021-07-14

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol ：我国不限瘤种PD-L1快要来了，晚期实体瘤患者精准治疗新选择！

2021-07-08

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：新发现可揭开运动员使用血液兴奋剂的面纱

2021-06-25

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：ixazomib口服治疗方案有望成为NDMM患者的良好替代治疗选择

2021-06-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：纳武单抗治疗复发或难治性霍奇金淋巴瘤的疗效——真实世界研究证据

2021-06-08

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：多发性骨髓瘤移植后依沙佐米维持治疗中不良事件的管理

2021-05-31

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：靶向捕获测序对多发性骨髓瘤进行基因组分析

2021-05-31

科室
- - 订阅+
  - 更多科室
工具
服务